Growth Metrics

Armata Pharmaceuticals (ARMP) Non-cash Items (2016 - 2026)

Quarterly results put Non-cash Items at $2.9 million for Q1 2026, up 21.06% from a year ago — trailing twelve months through Mar 2026 was $2.9 million (up 21.06% YoY), and the annual figure for FY2025 was $15.0 million, up 376025.0%.

Armata Pharmaceuticals has reported Non-cash Items over the past 13 years, most recently at $2.9 million for Q1 2026.

  • Non-cash Items reached $2.9 million in Q1 2026 per ARMP's latest filing, down from $15.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $15.0 million in Q4 2025 and bottomed at $4000.0 in Q4 2024.
  • Median Non-cash Items over the past 5 years was $1.5 million (2023), compared with a mean of $2.3 million.
  • The largest annual shift saw Non-cash Items tumbled 99.3% in 2024 before it surged 376025.0% in 2025.
  • Over 5 years, Non-cash Items stood at $1.4 million in 2022, then tumbled by 70.17% to $429000.0 in 2023, then crashed by 99.07% to $4000.0 in 2024, then soared by 376025.0% to $15.0 million in 2025, then plummeted by 80.59% to $2.9 million in 2026.
  • Business Quant data shows Non-cash Items for ARMP at $2.9 million in Q1 2026, $15.0 million in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 605.66 Bn 605.66 Bn -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn
8 Evaxion A 65.12 Bn 65.10 Bn -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.92 Mn
Mar 31, 2026 2.92 Mn
Dec 31, 2025 15.05 Mn
Dec 31, 2025 15.05 Mn
Sep 30, 2025 1.62 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 2.47 Mn
Jun 30, 2025 2.47 Mn
Mar 31, 2025 2.41 Mn
Mar 31, 2025 2.41 Mn
Dec 31, 2024 4,000.00
Dec 31, 2024 4,000.00
Sep 30, 2024 15,000.00
Sep 30, 2024 15,000.00
Jun 30, 2024 144,000.00
Jun 30, 2024 144,000.00
Mar 31, 2024 3.33 Mn
Mar 31, 2024 3.33 Mn
Dec 31, 2023 429,000.00
Dec 31, 2023 429,000.00
Sep 30, 2023 2.14 Mn
Sep 30, 2023 2.14 Mn
Jun 30, 2023 1.70 Mn
Jun 30, 2023 1.70 Mn
Mar 31, 2023 1.53 Mn
Mar 31, 2023 1.53 Mn
Dec 31, 2022 1.44 Mn
Dec 31, 2022 1.44 Mn
Sep 30, 2022 1.29 Mn
Sep 30, 2022 1.29 Mn
Jun 30, 2022 1.27 Mn
Jun 30, 2022 1.27 Mn
Mar 31, 2022 952,421.00
Mar 31, 2022 952,421.00
Dec 31, 2021 2.40 Mn
Dec 31, 2021 2.40 Mn
Sep 30, 2021 733,721.00
Sep 30, 2021 733,721.00
Jun 30, 2021 744,996.00
Jun 30, 2021 744,996.00
Mar 31, 2021 2.31 Mn
Mar 31, 2021 2.31 Mn
Dec 31, 2020 3.40 Mn
Dec 31, 2020 3.40 Mn
Sep 30, 2020 425,114.00
Sep 30, 2020 425,114.00
Jun 30, 2020 923,000.00
Jun 30, 2020 923,000.00
Mar 31, 2020 169,558.00
Mar 31, 2020 169,558.00
Dec 31, 2019 1.48 Mn
Dec 31, 2019 1.48 Mn
Sep 30, 2019 1.51 Mn
Sep 30, 2019 1.51 Mn
Jun 30, 2019 179,202.00
Jun 30, 2019 179,202.00
Mar 31, 2019 502,392.00
Mar 31, 2019 502,392.00
Dec 31, 2018 402,642.00
Dec 31, 2018 402,642.00
Sep 30, 2018 118,000.00
Sep 30, 2018 118,000.00
Jun 30, 2018 174,578.00
Jun 30, 2018 174,578.00
Mar 31, 2018 146,162.00
Mar 31, 2018 146,162.00
Dec 31, 2017 118,000.00
Dec 31, 2017 118,000.00
Sep 30, 2017 131,928.00
Sep 30, 2017 131,928.00
Jun 30, 2017 5,932.00
Jun 30, 2017 5,932.00
Mar 31, 2017 39,766.00
Mar 31, 2017 39,766.00
Dec 31, 2016 1.40 Mn
Dec 31, 2016 1.40 Mn
Sep 30, 2016 1.90 Mn
Sep 30, 2016 1.90 Mn
Jun 30, 2016 154,312.00
Jun 30, 2016 154,312.00